What does Exo Biologics do?
EXO Biologics is a biotechnology company specializing in the development of innovative exosome-based therapies for various medical conditions. The company focuses on harnessing the natural properties of exosomes to create targeted treatments that improve patient outcomes. By advancing the understanding of exosome biology, EXO Biologics aims to revolutionize the field of regenerative medicine.
- Signals
-
Reporting lossesReporting losses € -2.32M
The company reported a loss in the latest financial year.
Negative cashflowNegative cashflow € -1.61MOperating cash flow was negative in the latest financial year.
Negative EBITDANegative EBITDA € -1.17MEBITDA is negative: operating activities are loss-making.
Strong equityStrong equity € 2.93MStrong equity provides a buffer against setbacks.
Healthy social debtHealthy social debt 12.9%Social debts stay manageable relative to personnel costs.
- Directors
- Margarite Limited S. Etr., Noshaq Partners Srl, Jean Michel Foidart, +1 more
- Investments
- Exoxpert 100%
Financial ratios
|
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Turnover
|
-
|
|
|
|
|
€
409K
|
€
2.77M
|
€
-225K
|
€
541K
|
|
|
€
-1.17M
|
€
1.29M
|
€
-2.95M
|
€
-465K
|
|
|
€
-2.32M
|
€
-2.06M
|
€
-5.13M
|
€
-393K
|
|
|
€
2.93M
|
€
3.25M
|
€
4.81M
|
€
-3.24M
|
|
|
25.02%
|
25.92%
|
53.25%
|
-103.79%
|
|
|
€
8.77M
|
€
9.30M
|
€
4.22M
|
€
6.36M
|
|
|
€
158K
|
€
1.02M
|
€
2.44M
|
€
517K
|
|
|
5
|
7
|
19.50
|
12
|
Publications 10
All publications- Statuts (Traduction, Coordination, Autres Modifications, ) - Capital, Actions 20/12/2024
- Statuts (Traduction, Coordination, Autres Modifications, ) - Capital, Actions 13/09/2024
- Demissions, Nominations 21/06/2024
- Demissions, Nominations 04/03/2024
- Statuts (Traduction, Coordination, Autres Modifications, ) - Capital, Actions 16/02/2024
Frequently asked questions
Answers to the most common questions about Exo Biologics, based on official government data and the filed annual accounts.
What is the VAT number of Exo Biologics?
The VAT number of Exo Biologics is BE0732.982.379.
How many employees work at Exo Biologics?
In 2025, Exo Biologics employed 5.00 full-time equivalents (FTE).
When was Exo Biologics established?
Exo Biologics was founded in 29-08-2019.
What is the official address of Exo Biologics?
The official address of Exo Biologics is Boulevard De Patience Et Beaujonc 3/2 Liège 4000.
What is the legal form of Exo Biologics?
The juridical form of Exo Biologics is Public limited company (NV/SA).
What is the annual revenue of Exo Biologics?
The 2025 accounts of Exo Biologics do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Exo Biologics do?
EXO Biologics is a biotechnology company specializing in the development of innovative exosome-based therapies for various medical conditions. The company focuses on harnessing the natural properties of exosomes to create targeted treatments that improve patient outcomes. By advancing the understanding of exosome biology, EXO Biologics aims to revolutionize the field of regenerative medicine.
Is Exo Biologics a reliable company?
Exo Biologics is a registered Rechtspersoon with company number 0732.982.379 and can be verified through the official CBE database.
What is the credit limit of Exo Biologics?
The estimated credit limit of Exo Biologics is €104,064.
Is Exo Biologics still active?
Exo Biologics currently has the status "Normal situation" and is active.